Genetically Targeted Enzyme Replacement Therapy

· Celladon Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Genetically Targeted Enzyme Replacement Therapy, covering 2014-08-20 to 2016-03-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure [Phase 2]